Skip to content
OpenCapital
Get started

Xeris Biopharma Holdings, Inc. XERS Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Corcept Therapeutics logo
Corcept TherapeuticsCORT
104.4M-12.8%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
31.5M+17.3%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
100.6M+4.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
60.2M+11.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
21.5M+7.5%

Other financials

Income statement

See full
Revenue$83.1M+38.3%
Gross profit$72.6M+41.2%
Operating income$7.9M+356%
Net income$2.2M+124%
EPS (diluted)$0.01+117%

Balance sheet

See full
Cash & equivalents$111.8M+91.2%
Total debt$258.6M-3.8%
Total equity$13.0M+137%
Total assets$392.0M+24.3%

Cash flow

See full
Operating cash flow$9.9M+198%
CapEx$131.0K—
Free cash flow-$29.1M—

Valuation

See full
Market cap$1.28B+76.9%
Enterprise value$1.42B+52.7%
P/E106.4×—
P/S4.1×+0.8×

Profitability

See full
Gross margin85.9%+3.7pp
Operating margin11.4%+7.7pp
Net margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-209.8%—
Debt / equity19.9×—
Current ratio2.1×+0.4×

Where this comes from

Reported directly by Xeris Biopharma Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s shares (diluted)?
Xeris Biopharma Holdings, Inc. (XERS) reported shares (diluted) of 177.6M in Q1 2026.
How has Xeris Biopharma Holdings, Inc.'s shares (diluted) changed year-over-year?
Xeris Biopharma Holdings, Inc.'s shares (diluted) increased by 16.5% year-over-year, from 152.4M to 177.6M.
What is the long-term trend for Xeris Biopharma Holdings, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s shares (diluted) has grown at a 24.8% compound annual growth rate (CAGR), from 273.1M to 662.3M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.